These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 33131967

  • 1. Correction to: YAN, a novel microtubule inhibitor, inhibits P-gp and MRP1 function and induces mitotic slippage followed by apoptosis in multidrug-resistant A549/Taxol cells.
    Gao M, Liu T, Li J, Guan Q, Wang H, Yan S, Li Z, Zuo D, Zhang W, Wu Y.
    Toxicol In Vitro; 2021 Apr; 72():105033. PubMed ID: 33131967
    [No Abstract] [Full Text] [Related]

  • 2. YAN, a novel microtubule inhibitor, inhibits P-gp and MRP1 function and induces mitotic slippage followed by apoptosis in multidrug-resistant A549/Taxol cells.
    Gao M, Liu T, Li J, Guan Q, Wang H, Yan S, Li Z, Zuo D, Zhang W, Wu Y.
    Toxicol In Vitro; 2020 Dec; 69():104971. PubMed ID: 32805372
    [Abstract] [Full Text] [Related]

  • 3. MAY, a novel tubulin inhibitor, induces cell apoptosis in A549 and A549/Taxol cells and inhibits epithelial-mesenchymal transition in A549/Taxol cells.
    Du J, Li J, Gao M, Guan Q, Liu T, Wu Y, Li Z, Zuo D, Zhang W, Wu Y.
    Chem Biol Interact; 2020 May 25; 323():109074. PubMed ID: 32217108
    [Abstract] [Full Text] [Related]

  • 4. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
    Bai Z, Gao M, Zhang H, Guan Q, Xu J, Li Y, Qi H, Li Z, Zuo D, Zhang W, Wu Y.
    Cancer Lett; 2017 Aug 28; 402():81-92. PubMed ID: 28576750
    [Abstract] [Full Text] [Related]

  • 5. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Kebsa W, Lahouel M, Rouibah H, Zihlif M, Ahram M, Abu-Irmaileh B, Mustafa E, Al-Ameer HJ, Al Shhab M.
    Anticancer Agents Med Chem; 2018 Aug 28; 18(9):1330-1337. PubMed ID: 30088453
    [Abstract] [Full Text] [Related]

  • 6. Overcoming resistance to mitochondrial apoptosis by BZML-induced mitotic catastrophe is enhanced by inhibition of autophagy in A549/Taxol cells.
    Bai Z, Gao M, Xu X, Zhang H, Xu J, Guan Q, Wang Q, Du J, Li Z, Zuo D, Zhang W, Wu Y.
    Cell Prolif; 2018 Aug 28; 51(4):e12450. PubMed ID: 29493085
    [Abstract] [Full Text] [Related]

  • 7. Distinct mechanisms of taxol-induced serine phosphorylation of the 66-kDa Shc isoform in A549 and RAW 264.7 cells.
    Yang CP, Horwitz SB.
    Biochim Biophys Acta; 2002 Jun 12; 1590(1-3):76-83. PubMed ID: 12063170
    [Abstract] [Full Text] [Related]

  • 8. Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers.
    Chen YL, Yang TY, Chen KC, Wu CL, Hsu SL, Hsueh CM.
    Cell Oncol (Dordr); 2016 Oct 12; 39(5):411-433. PubMed ID: 27306525
    [Abstract] [Full Text] [Related]

  • 9. Chelidonine induces mitotic slippage and apoptotic-like death in SGC-7901 human gastric carcinoma cells.
    Qu Z, Zou X, Zhang X, Sheng J, Wang Y, Wang J, Wang C, Ji Y.
    Mol Med Rep; 2016 Feb 12; 13(2):1336-44. PubMed ID: 26677104
    [Abstract] [Full Text] [Related]

  • 10. Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin.
    Lin H, Hu B, He X, Mao J, Wang Y, Wang J, Zhang T, Zheng J, Peng Y, Zhang F.
    Biochem Pharmacol; 2020 Jan 12; 171():113733. PubMed ID: 31783010
    [Abstract] [Full Text] [Related]

  • 11. Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells.
    Yang CP, Galbiati F, Volonte D, Horwitz SB, Lisanti MP.
    FEBS Lett; 1998 Nov 20; 439(3):368-72. PubMed ID: 9845355
    [Abstract] [Full Text] [Related]

  • 12. Survivin deregulation in beta-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to taxol.
    Zhou J, O'brate A, Zelnak A, Giannakakou P.
    Cancer Res; 2004 Dec 01; 64(23):8708-14. PubMed ID: 15574781
    [Abstract] [Full Text] [Related]

  • 13. Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors.
    Aronica E, Gorter JA, Jansen GH, van Veelen CW, van Rijen PC, Leenstra S, Ramkema M, Scheffer GL, Scheper RJ, Troost D.
    Neuroscience; 2003 Dec 01; 118(2):417-29. PubMed ID: 12699778
    [Abstract] [Full Text] [Related]

  • 14. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P, Chearwae W, Shukla S, Phisalphong C, Ambudkar SV.
    Mol Cell Biochem; 2007 Feb 01; 296(1-2):85-95. PubMed ID: 16960658
    [Abstract] [Full Text] [Related]

  • 15. Gene expression and mitotic exit induced by microtubule-stabilizing drugs.
    Chen JG, Yang CP, Cammer M, Horwitz SB.
    Cancer Res; 2003 Nov 15; 63(22):7891-9. PubMed ID: 14633718
    [Abstract] [Full Text] [Related]

  • 16. Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression, and drug transporter-mediated activity in a human intestinal cell line.
    Perloff MD, Von Moltke LL, Marchand JE, Greenblatt DJ.
    J Pharm Sci; 2001 Nov 15; 90(11):1829-37. PubMed ID: 11745741
    [Abstract] [Full Text] [Related]

  • 17. The Novel Triazolonaphthalimide Derivative LSS-11 Synergizes the Anti-Proliferative Effect of Paclitaxel via STAT3-Dependent MDR1 and MRP1 Downregulation in Chemoresistant Lung Cancer Cells.
    Ji L, Liu X, Zhang S, Tang S, Yang S, Li S, Qi X, Yu S, Lu L, Meng X, Liu Z.
    Molecules; 2017 Oct 26; 22(11):. PubMed ID: 29072615
    [Abstract] [Full Text] [Related]

  • 18. RNAi-based knockdown of multidrug resistance-associated protein 1 is sufficient to reverse multidrug resistance of human lung cells.
    Shao SL, Cui TT, Zhao W, Zhang WW, Xie ZL, Wang CH, Jia HS, Liu Q.
    Asian Pac J Cancer Prev; 2014 Oct 26; 15(24):10597-601. PubMed ID: 25605145
    [Abstract] [Full Text] [Related]

  • 19. Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1.
    Tang R, Faussat AM, Majdak P, Perrot JY, Chaoui D, Legrand O, Marie JP.
    Leukemia; 2004 Jul 26; 18(7):1246-51. PubMed ID: 15116123
    [Abstract] [Full Text] [Related]

  • 20. Mitotic kinesin inhibitors induce mitotic arrest and cell death in Taxol-resistant and -sensitive cancer cells.
    Marcus AI, Peters U, Thomas SL, Garrett S, Zelnak A, Kapoor TM, Giannakakou P.
    J Biol Chem; 2005 Mar 25; 280(12):11569-77. PubMed ID: 15653676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.